Groundbreaking Study in NEJM: Key Insights Ahead of Print
In this week’s New England Journal of Medicine, researchers report that inhaled treprostinil—a vasodilator (a drug that widens blood vessels) approved for pulmonary hypertension—has shown statistically significant (p < 0.05) ... Read More